Scholarships for MSc programma in vaccinology in Siena, Italy
The University of Siena Medical School, Novartis Vaccines and Diagnostics, Novartis Vaccines Institute for Global Health (NVGH), and the ADITEC (Advanced Immunization Technologies) programme invite applications for the Master Programme in Vaccinology and Pharmaceutical Clinical Development (IV edition 2015) commencing in May 2015. Scholarships will be offered to selected applicants. Physicians involved in vaccine development projects funded by the European & Developing Countries Clinical Trials Partnership (EDCTP) are encouraged to apply.
Programme
The programme offers a one-year course at the University of Siena in Italy followed by a six-month internship at Novartis Vaccines, Sanofi-Pasteur, Universities of Surrey, University of Oxford or University Hospital of Siena. Field training at various investigational sites involved in vaccine trials is also included. The MSc course will provide physicians interested in public health and infectious diseases an opportunity to learn about vaccine preventable diseases, vaccine development from research to licensure, vaccine policy and funding.
Entry requirements
Scholarships are offered through Novartis and the EU FP7 ADITEC programme. Eligibility has been extended to applicants working in EDCTP-funded vaccine development projects. As scholarships are limited, applications will go through a competitive selection process. An 18-month grant will be provided to accepted applicants.
Entry requirements are a university degree in human medicine and excellent command of written and spoken English. ADITEC sponsored candidates must be currently working in a European Union or Associated Member State or in a vaccine development project funded by the European Commission or EDCTP.
Application
Candidates must send the official application form to the University of Siena by 5 February 2015. For further information, contact Novartis Vaccines Academy – Master Program Coordination at vaccines_master.nvxit[at]novartis.com by 20 November 2014.
Background
The objective of the Masters programme is to build capacity in vaccinology and vaccine development in developing countries. The programme prepares students for a career in academia, public health or Research & Development in public and private vaccine institutes.
The programme is open to physicians involved in vaccine development projects funded by the European & Developing Countries Clinical Trials Partnership (EDCTP) as a result of collaboration between Novartis and the European Commission.
The initiative is part of a broader EDCTP effort to foster cooperation of public and private partners for clinical research on poverty-related diseases and neglected infectious diseases.